Eventide Asset Management, LLC 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 11:55 am Sale | 2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Eventide Asset Management, LLC | 42,499 0.100% | -2,795,626![]() (-98.50%) | Filing |
2021-02-12 4:11 pm Purchase | 2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Eventide Asset Management, LLC | 2,838,125 8.000% | 2,838,125![]() (New Position) | Filing |